Investing.com -- Fears over the economy are set to remain to the fore amid worries that the Federal Reserve may have left interest rates elevated for too long, allowing them to ...

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...

Terns Pharmaceuticals recently posted positive results from a clinical trial involving a weight-loss pill. The results looked ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

BMO Capital维持对Eli Lilly股票（NYSE:LLY）的"优于大盘"评级，目标价为1,101.00美元。该公司强调了Eli ...

Eli Lilly and Company (NYSE: LLY)今天宣布,其用于开始胰岛素治疗的2型糖尿病成年患者的每周一次胰岛素efsitora alfa ...

Eli Lilly’s stock has climbed almost 60% this year and trades for more than $900. The pharma giant also has seen soaring ...

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...